Peter Altmaier (l), Federal Minister of Economics and Technology, and Ulrich Nu'baum (r), State Secretary in the Federal Ministry of Economics, take part in a press conference with Franz-Werner Haas (on screen), CEO of the biotech company Curevac, and the investor Hopp.
July 21, 2020 07:30 AM EDT
Financing
Coronavirus

GSK, Ger­many push coro­n­avirus-fo­cused mR­NA play­er Cure­Vac's lat­est round to $640M

Amber Tong

Af­ter court­ing some high-pro­file in­vestors, Cure­Vac has closed a whop­ping $640 mil­lion (€560 mil­lion) in its lat­est round.

The biotech an­nounced the fi­nanc­ing in a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times